Tajima Y, Yamazaki K, Makino R, Nishino N, Masuda Y, Aoki S, Kato M, Morohara K, Kusano M
1Division of General and Gastroenterological Surgery, Department of Surgery, Showa University, School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.
Br J Cancer. 2007 Feb 26;96(4):631-8. doi: 10.1038/sj.bjc.6603583. Epub 2007 Jan 30.
Adenocarcinoma of the gastric cardia (C-Ca) is possibly a specific subtype of gastric carcinoma. The purpose of this study was to clarify the differences in the clinicopathological characteristics between C-Ca and adenocarcinoma of the distal stomach (D-Ca), and also the differences in the expressions of gastric and intestinal phenotypic markers and genetic alterations between the two. The clinicopathological findings in 72 cases with C-Ca were examined and compared with those in 170 cases with D-Ca. The phenotypic marker expressions examined were those of human gastric mucin (HGM), MUC6, MUC2 and CD10. Furthermore, the presence of mutations in the APC, K-ras and p53 genes and the microsatellite instability status of the tumour were also determined. C-Ca was associated with a significantly higher incidence of differentiated-type tumours and lymphatic vessel invasion (LVI) as compared with D-Ca (72.2 vs 48.2%, P=0.0006 and 72.2 vs 55.3%, P=0.0232, respectively). Oesophageal invasion by the tumour beyond the oesophago-gastric junction (OGJ) was found in 56.9% of cases with C-Ca; LVI in the area of oesophageal invasion was demonstrated in 61% of these cases. Also, LVI was found more frequently in cases of C-Ca with oesophageal invasion than in those without oesophageal invasion (82.9 vs 58.1%, P=0.0197). The incidence of undifferentiated-type tumours was significantly higher in cases with advanced-stage C-Ca than in those with early-stage C-Ca (5 vs 36.5%, P=0.0076). A significantly greater frequency of HGM expression in early-stage C-Ca and significantly lower frequency of MUC2 expression in advanced-stage C-Ca was observed as compared with the corresponding values in cases of D-Ca (78.9 vs 52.2%, P=0.0402 and 51.5 vs 84.6%, P=0.0247, respectively). Mutation of the APC gene was found in only one of all cases of C-Ca, and the frequency of mutation of the APC gene was significantly lower in cases of C-Ca than in those of D-Ca (2.4 vs 20.0%, P=0.0108). The observations in this study suggest that C-Ca is a more aggressive tumour than D-Ca. The differences in biological behavior between C-Ca and D-Ca may result from the different histological findings in the wall of the OGJ and the different genetic pathways involved in the carcinogenesis.
贲门腺癌(C-Ca)可能是胃癌的一种特殊亚型。本研究的目的是阐明C-Ca与胃远端腺癌(D-Ca)在临床病理特征上的差异,以及两者在胃和肠表型标志物表达及基因改变方面的差异。对72例C-Ca患者的临床病理结果进行了检查,并与170例D-Ca患者的结果进行了比较。所检测的表型标志物表达包括人胃黏液素(HGM)、MUC6、MUC2和CD10。此外,还确定了APC、K-ras和p53基因的突变情况以及肿瘤的微卫星不稳定性状态。与D-Ca相比,C-Ca中分化型肿瘤和淋巴管侵犯(LVI)的发生率显著更高(分别为72.2%对48.2%,P = 0.0006;72.2%对55.3%,P = 0.0232)。在56.9%的C-Ca病例中发现肿瘤侵犯食管超过食管胃交界(OGJ);在这些病例中,61%的食管侵犯区域存在LVI。此外,有食管侵犯的C-Ca病例中LVI的发生率高于无食管侵犯的病例(82.9%对58.1%,P = 0.0197)。晚期C-Ca病例中未分化型肿瘤的发生率显著高于早期C-Ca病例(5%对36.5%,P = 0.0076)。与D-Ca病例的相应值相比,观察到早期C-Ca中HGM表达频率显著更高,晚期C-Ca中MUC2表达频率显著更低(分别为78.9%对52.2%,P = 0.0402;51.5%对84.6%,P = 0.0247)。在所有C-Ca病例中仅发现1例APC基因突变,C-Ca病例中APC基因突变频率显著低于D-Ca病例(2.4%对20.0%,P = 0.0108)。本研究的观察结果表明,C-Ca是比D-Ca更具侵袭性的肿瘤。C-Ca和D-Ca之间生物学行为的差异可能源于OGJ壁不同的组织学表现以及致癌过程中涉及的不同基因途径。